1、娼搀(睌省搀翽激秮省睚省睌省讀缁缀耀螏礀頀h椀鄀唍唍唍納納納納納納納納納納納納納納納納納納缍伀洀椀渀漀攀琀栀礀氀栀礀搀爀漀砀礀瘀椀琀愀洀椀渀礀搀爀漀砀礀嘀椀琀愀洀椀渀洀椀渀漀瀀爀漀瀀礀氀琀栀攀爀嘀嘀刀栀攀洀椀挀愀氀攀搀栀攀洀砀瀀爀攀猀猀瀀搀昀瀀椀挀最椀昀伀洀椀渀漀攀琀栀礀氀栀礀搀爀漀砀礀瘀椀琀愀洀椀渀礀搀爀漀砀礀嘀椀琀愀洀椀渀洀椀渀漀瀀爀漀瀀礀氀琀栀攀爀嘀嘀刀瀀搀昀尀尀挀搀昀戀戀愀攀搀昀搀攀爀挀焀焀漀一戀猀攀洀稀戀搀樀伀甀焀圀瀀搀洀堀唀一栀渀礀匀猀最洀椀渀漀攀琀栀礀氀栀礀搀爀漀砀礀瘀椀琀愀洀椀渀礀搀爀漀砀礀嘀椀琀愀洀椀渀洀椀渀漀瀀爀漀瀀礀氀琀栀攀爀嘀嘀刀挀戀昀攀搀挀愀昀昀挀昀搀攀挀愀伀洀椀渀漀
2、攀琀栀礀氀栀礀搀爀漀砀礀瘀椀琀愀洀椀渀愀琀一漀夀匀一漀茀耠蔀脠丠伀舀尀摏瘯嘀嘀刀尀摏嘀椀琀愀洀椀渀刀攀氀愀琀攀搀塐瀀爀漀琀攀挀琀昀爀漀洀氀椀最栀琀猀琀漀爀攀搀甀渀搀攀爀渀椀琀爀漀最攀渀灠湥卣鹙豛匀伀攀洀最洀洀攠洀攀愀渀猀猀漀氀甀戀氀攀戀甀琀猀愀琀甀爀愀琀椀漀渀甀渀欀渀漀眀渀漀渀挀攀渀琀爀愀琀椀漀渀匀漀氀瘀攀渀琀愀猀猀洀最洀最洀最洀洀洀洀洀洀洀洀洀洀洀洀湨葎蒐卭蕏鹑豛鶋轏匀伀最琀最琀挀漀爀渀漀椀氀匀漀氀甀戀椀氀椀琀礀攀洀最洀洀氀攀愀爀猀漀氀甀琀椀漀渀鶋轏匀伀最琀最琀匀椀渀猀愀氀椀渀攀匀漀氀甀戀椀氀椀琀礀攀洀最洀洀氀攀愀爀猀漀氀甀琀椀漀渀鶋轏匀伀最琀最琀倀最琀最琀吀眀攀攀渀最琀最琀猀愀氀椀渀攀匀漀
3、氀甀戀椀氀椀琀礀攀洀最洀洀氀攀愀爀猀漀氀甀琀椀漀渀伀伀吀嘀吀夀挀椯伀洀椀渀漀攀琀栀礀氀栀礀搀爀漀砀礀瘀椀琀愀洀椀渀f嘀椀琀愀洀椀渀授椯蔀耠愀砀洀愀椀氀琀攀挀栀攀搀栀攀洀砀瀀爀攀猀猀挀渀愀猀琀攀爀漀昀匀洀愀氀氀漀氀攀挀甀氀攀猀鵠蒏酶睞眀眀攀搀栀攀洀砀瀀爀攀猀猀挀渀攀搀栀攀洀砀瀀爀攀猀猀靓?蔀态戁谐感0g言茀渀7砀礀墾:#钸#胔-輀棙i缀$Azasetron-hydrochloride-(Y-25130-hydrochloride)-5-HT-Receptor-Antagonist-MedChemExpress.pdfpic1.gifAzasetronhydrochloride(Y25130hyd
4、rochloride)5HTReceptorAntagonistMedChemExpress.pdf2019-626053aa5a6-108d-4d2c-93aa-97e8f1fb4f8ayYHdvZrMTsB3wI/CHzk2j+oZI6p1r3SE6/ejwPeNzq9Qahy9xMBkQw=Azasetron,hydrochloride,25130,HT,Receptor,Antagonist,MedChemExpressfb18558896a24a2bdc6140efa67a7336Azasetron hydrochlorideCat. No.: HY-B0068CAS No.: 12
5、3040-16-4分式: CHClNO分量: 386.27作靶点: 5-HT Receptor作通路: GPCR/G Protein; Neuronal Signaling储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 H2O : 3.9 mg/mL (10.10 mM)* “ means soluble, but saturation unknown.ConcentrationSolvent Mass 1 mg 5 mg 10 mg1 mM 2.5889 mL 12.9443 mL
6、 25.8886 mL5 mM 0.5178 mL 2.5889 mL 5.1777 mL制备储备液10 mM 0.2589 mL 1.2944 mL 2.5889 mL请根据产品在不同溶剂中的溶解度，选择合适的溶剂配制储备液BIOLOGICAL ACTIVITY物活性 Azasetron盐酸盐是5- HT3受体选择性拮抗剂， IC50为0.33 nM。客户使本产品发表的科研献See more customer validations on www.MedChemEREFERENCESProduct Data Sheet InhibitorsAgonistsScreening Librarie
7、s Protein Cell. 2019 Mar;10(3):178-195.www.MedChemE11. Sato, N., et al., Antagonistic activity of Y-25130 on 5-HT3 receptors. Jpn J Pharmacol, 1992. 59(4): p. 443-8.2. Haga, K., et al., The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis. Jpn J Pharmacol, 199
